Search

Search Constraints

You searched for: Author/Creator Repousis, Panagiotis

Search Results

1. Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience. Issue 1 (20th February 2017)

2. Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group. Issue 1 (January 2020)

4. Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents. (26th January 2014)

5. Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse. Issue 7 (1st July 2013)

6. Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse. Issue 7 (July 2013)

7. Re‐evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents. Issue 2 (7th September 2012)

8. The effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes. (30th August 2020)

9. The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry. (21st March 2019)